GB0012795D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB0012795D0
GB0012795D0 GBGB0012795.1A GB0012795A GB0012795D0 GB 0012795 D0 GB0012795 D0 GB 0012795D0 GB 0012795 A GB0012795 A GB 0012795A GB 0012795 D0 GB0012795 D0 GB 0012795D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
preparation
compounds
medicaments
substituents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0012795.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0012795.1A priority Critical patent/GB0012795D0/en
Publication of GB0012795D0 publication Critical patent/GB0012795D0/en
Priority to ES01943442T priority patent/ES2261422T3/es
Priority to EP01943442A priority patent/EP1290012B1/en
Priority to PCT/EP2001/005952 priority patent/WO2001089282A2/en
Priority to US10/258,901 priority patent/US20030166572A1/en
Priority to DE60119514T priority patent/DE60119514T2/de
Priority to PT01943442T priority patent/PT1290012E/pt
Priority to CA002405871A priority patent/CA2405871A1/en
Priority to AU2001266019A priority patent/AU2001266019A1/en
Priority to JP2001585538A priority patent/JP2003533541A/ja
Priority to AT01943442T priority patent/ATE325809T1/de
Priority to US11/434,398 priority patent/US20060205673A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0012795.1A 2000-05-25 2000-05-25 Organic compounds Ceased GB0012795D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB0012795.1A GB0012795D0 (en) 2000-05-25 2000-05-25 Organic compounds
AT01943442T ATE325809T1 (de) 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl- amino-5-phenyl-pentansäure
US10/258,901 US20030166572A1 (en) 2000-05-25 2001-05-23 2-Amino-3-hydroxy-4-tert-leucyl-amino-5 phenyl-pentanoic acid amide derivatives
EP01943442A EP1290012B1 (en) 2000-05-25 2001-05-23 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
PCT/EP2001/005952 WO2001089282A2 (en) 2000-05-25 2001-05-23 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
ES01943442T ES2261422T3 (es) 2000-05-25 2001-05-23 Derivados de amida de acido 2-amino-3-hidroxi-4-terc-leucilamino-5-fenilpentanoico.
DE60119514T DE60119514T2 (de) 2000-05-25 2001-05-23 Amidderivate der 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentansäure
PT01943442T PT1290012E (pt) 2000-05-25 2001-05-23 Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico
CA002405871A CA2405871A1 (en) 2000-05-25 2001-05-23 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
AU2001266019A AU2001266019A1 (en) 2000-05-25 2001-05-23 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
JP2001585538A JP2003533541A (ja) 2000-05-25 2001-05-23 ２−アミノ−３−ヒドロキシ−４−ｔｅｒｔ−ロイシル−アミノ−５−フェニル−ペンタン酸アミド誘導体
US11/434,398 US20060205673A1 (en) 2000-05-25 2006-05-15 2-Amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0012795.1A GB0012795D0 (en) 2000-05-25 2000-05-25 Organic compounds

Publications (1)

Publication Number Publication Date
GB0012795D0 true GB0012795D0 (en) 2000-07-19

Family

ID=9892401

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0012795.1A Ceased GB0012795D0 (en) 2000-05-25 2000-05-25 Organic compounds

Country Status (11)

Country Link
US (2) US20030166572A1 (https=)
EP (1) EP1290012B1 (https=)
JP (1) JP2003533541A (https=)
AT (1) ATE325809T1 (https=)
AU (1) AU2001266019A1 (https=)
CA (1) CA2405871A1 (https=)
DE (1) DE60119514T2 (https=)
ES (1) ES2261422T3 (https=)
GB (1) GB0012795D0 (https=)
PT (1) PT1290012E (https=)
WO (1) WO2001089282A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351738B2 (en) * 2002-11-27 2008-04-01 Elan Pharmaceuticals, Inc. Substituted ureas and carbamates
GB0504950D0 (en) * 2005-03-10 2005-04-20 Novartis Ag Organic compositions
CA2604133C (en) 2005-04-07 2015-12-01 Centre National De La Recherche Scientifique Compounds useful as modulators of the proteasome activity
BRPI0907805A2 (pt) * 2008-02-28 2015-07-14 Novartis Ag Combinações para tratar dor associada à hiv
WO2010096574A1 (en) 2009-02-20 2010-08-26 Lisanti Michael P A method of diagnosis or prognosis of a neoplasm comprising determining the level of expression of a protein in stromal cells adjacent to the neoplasm
GB2523211B (en) 2012-01-27 2020-03-18 Univ Jefferson MCT protein inhibitor-related prognostic and therapeutic methods
WO2014172627A1 (en) 2013-04-19 2014-10-23 Thomas Jefferson University Caveolin-1 related methods for treating glioblastoma with temozolomide
CN112867706B (zh) * 2018-05-29 2024-11-15 奥默罗斯公司 Masp-2抑制剂和使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives
EP0982317A1 (en) * 1998-08-26 2000-03-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Bivalent inhibitors of the proteasome
BR0010134A (pt) * 1999-04-27 2002-01-15 Novartis Ag Uso de derivados de ácido 2,4-diamino-3-hidroxicarboxìlico como inibidores de proteassoma

Also Published As

Publication number Publication date
US20060205673A1 (en) 2006-09-14
ES2261422T3 (es) 2006-11-16
DE60119514D1 (de) 2006-06-14
CA2405871A1 (en) 2001-11-29
WO2001089282A3 (en) 2002-05-10
US20030166572A1 (en) 2003-09-04
AU2001266019A1 (en) 2001-12-03
EP1290012A2 (en) 2003-03-12
PT1290012E (pt) 2006-09-29
JP2003533541A (ja) 2003-11-11
ATE325809T1 (de) 2006-06-15
EP1290012B1 (en) 2006-05-10
DE60119514T2 (de) 2006-10-05
WO2001089282A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
GB0022438D0 (en) Organic Compounds
GB0119249D0 (en) Organic compounds
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MXPA02012425A (es) Compuestos nuevos.
TW200500358A (en) Compounds
TW200510392A (en) Chemical compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
TW200615266A (en) Organic compounds
EP1633740A4 (en) CHEMICAL COMPOUNDS
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SE0302139D0 (sv) Novel compounds
BG108498A (en) New derivatives of oxazolidinones as antibacterial agents
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MXPA05010020A (es) Derivados de oxamida.
GB0012795D0 (en) Organic compounds
NO20044531L (no) Imidazolinylmetyl-aralkylsulfonamider, blandinger omfattende slike, fremgangsmate for fremstilling av slike, slike forbindelser som medikament samt anvendelse av slike forbindelser for fremstilling av medikamenter for behandling av sykdom
MXPA02012426A (es) Compuestos nuevos.
TW200504051A (en) Novel acridine derivatives and their use as medicaments
MY146802A (en) Novel drugs for treating respiratory diseases
TW200510379A (en) 1, 4-disubstituted piperidine compounds, their preparation and use as medicaments
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
GB0403606D0 (en) Organic compounds
ATE315038T1 (de) Antibakterielle mittel
ATE370733T1 (de) Pharmazeutische kombinationspräparat zur behandlung von spastischkeit und/oder schmerzen
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)